Transvaginal NOTES Cholecystectomy: Phase I/II Mexico Clinical Trial
Primary Purpose
Cholelithiasis
Status
Completed
Phase
Phase 1
Locations
Mexico
Study Type
Interventional
Intervention
Transvaginal NOTES cholecystectomy
Laparoscopic cholecystectomy
Sponsored by
About this trial
This is an interventional treatment trial for Cholelithiasis focused on measuring Transvaginal, NOTES, Cholecystectomy, Laparoscopic
Eligibility Criteria
Inclusion Criteria:
- Adult (> 18 years old) female patients residents of Durango Mexico.
- Patients who undergo elective surgery.
- Patients with ultrasound documented symptomatic cholelithiasis, gallbladder polyps of biliary dyskinesia.
- Patients capable of giving written informed consent for the study.
Exclusion Criteria:
- Patients who have contraindications prohibiting general anesthesia.
- Pregnancy.
- Previous abdominal or gynecological procedures.
- Uncontrollable medical or psychiatric conditions
- Elderly > 65 y/o.
- Body Mass Index > 35 mg/kg2.
- Complicated or acute cholecystitis.
- Elevation of liver function tests.
- Acute abdomen.
- Intra-abdominal abscess.
- Coagulopathy.
- Imperforated hymen.
Sites / Locations
- Universidad Juarez del Estado de Durango, Mexico
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Experimental
Arm Label
1
2
3
Arm Description
Transvaginal NOTES Cholecystectomy (Phase 1)
Laparoscopic Cholecystectomy (Phase 2)
Transvaginal NOTES cholecystectomy (Phase 2)
Outcomes
Primary Outcome Measures
Safety and Efficacy of Transvaginal NOTES cholecystectomy when compared to Laparoscopic cholecystectomy
Secondary Outcome Measures
Short term outcomes of Transvaginal NOTES cholecystectomy when compared to Laparoscopic Cholecystectomy
Full Information
NCT ID
NCT00710502
First Posted
July 2, 2008
Last Updated
December 14, 2009
Sponsor
Universidad Juárez del Estado de Durango
Collaborators
Hospital Universitario La Paz
1. Study Identification
Unique Protocol Identification Number
NCT00710502
Brief Title
Transvaginal NOTES Cholecystectomy: Phase I/II Mexico Clinical Trial
Official Title
Transvaginal Natural Orifice Translumenal and Endoscopic Surgery (NOTES) Cholecystectomy vs. Laparoscopic Cholecystectomy: Phase I/II Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2009
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Universidad Juárez del Estado de Durango
Collaborators
Hospital Universitario La Paz
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cholecystectomy is one of the most common general surgery procedures performed in the US today and is among top 10 procedures performed in U.S. hospitals annually, and biliary tract disease has been estimated to cost U.S. healthcare $5 billion/year. Laparoscopic cholecystectomy was introduced in the early 1990s and has become the standard surgical approach for the treatment of gallbladder disease. More than 500,000 cholecystectomy procedures are performed in the US every year. Laparoscopic cholecystectomy is now performed as an outpatient basis and is related to a very low complication rate. Laparoscopic cholecystectomy requires the use of multiple trocar incisions.
Natural Orifice Translumenal Endoscopic Surgery(NOTES) is a new type of surgical procedure currently being studied around the world. The idea of NOTES was developed several years ago in response to the concepts that patients would
realize the benefits of less invasive surgery by reducing the recovery time,
experience less physical discomfort associated with traditional procedures
have virtually no visible scarring following this type of surgery.
All of these advantages have spurred research and investigation forward, encouraging physicians and researchers to develop new equipment and techniques to use during NOTES procedures. Although the Natural Orifice Translumenal Endoscopic Surgery approach may hold tremendous potential, there are many issues that need to be addressed before this technique is introduced into clinical care.
The purpose of this study is to determine the safety, feasibility and short-term clinical outcomes (Phase I trial) of transvaginal NOTES cholecystectomy in female patients with symptomatic cholelithiasis and compare it to Laparoscopic Cholecystectomy (Phase II).
Hypothesis 1: Transvaginal NOTES cholecystectomy is safe and feasible in female patients with symptomatic cholelithiasis.
Hypothesis 2: The short term outcomes of Transvaginal NOTES cholecystectomy are comparable to Laparoscopic Cholecystectomy in female patients with symptomatic cholelithiasis.
Aim 1: Determine the safety of Transvaginal NOTES cholecystectomy. Aim 2: Determine the feasibility of Transvaginal NOTES cholecystectomy. Aim 3: Determine the short-term outcomes of Transvaginal NOTES cholecystectomy. Aim 4: Compare the short-term outcomes of Transvaginal NOTES cholecystectomy to Laparoscopic cholecystectomy.
Detailed Description
Most recently, surgeons and endoscopists have focused on NOTES cholecystectomy. Access to the abdominal cavity to perform NOTES procedures has been obtained by transgastric, transvaginal, transvesical and transrectal approaches. The first successful NOTES procedure in humans was an appendectomy in India. Transvaginal NOTES cholecystectomy has been successfully performed and reported in a handful of cases in the US, Europe and South America. However, to date, there is lack of clinical trials that demonstrate the safety and feasibility of Transvaginal NOTES cholecystectomy in a larger group of patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholelithiasis
Keywords
Transvaginal, NOTES, Cholecystectomy, Laparoscopic
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Transvaginal NOTES Cholecystectomy (Phase 1)
Arm Title
2
Arm Type
Active Comparator
Arm Description
Laparoscopic Cholecystectomy (Phase 2)
Arm Title
3
Arm Type
Experimental
Arm Description
Transvaginal NOTES cholecystectomy (Phase 2)
Intervention Type
Procedure
Intervention Name(s)
Transvaginal NOTES cholecystectomy
Other Intervention Name(s)
NOTES gallbladder removal, NOTES gallbladder surgery
Intervention Description
Under general anesthesia, patients will undergo Transvaginal NOTES cholecystectomy
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic cholecystectomy
Other Intervention Name(s)
Small incision gallbladder surgery
Intervention Description
Under general anesthesia, patients will undergo standard Laparoscopic cholecystectomy
Primary Outcome Measure Information:
Title
Safety and Efficacy of Transvaginal NOTES cholecystectomy when compared to Laparoscopic cholecystectomy
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Short term outcomes of Transvaginal NOTES cholecystectomy when compared to Laparoscopic Cholecystectomy
Time Frame
12 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult (> 18 years old) female patients residents of Durango Mexico.
Patients who undergo elective surgery.
Patients with ultrasound documented symptomatic cholelithiasis, gallbladder polyps of biliary dyskinesia.
Patients capable of giving written informed consent for the study.
Exclusion Criteria:
Patients who have contraindications prohibiting general anesthesia.
Pregnancy.
Previous abdominal or gynecological procedures.
Uncontrollable medical or psychiatric conditions
Elderly > 65 y/o.
Body Mass Index > 35 mg/kg2.
Complicated or acute cholecystitis.
Elevation of liver function tests.
Acute abdomen.
Intra-abdominal abscess.
Coagulopathy.
Imperforated hymen.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Homero Rivas, MD
Organizational Affiliation
Hospital de la Paz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universidad Juarez del Estado de Durango, Mexico
City
Durango
ZIP/Postal Code
34000
Country
Mexico
12. IPD Sharing Statement
Learn more about this trial
Transvaginal NOTES Cholecystectomy: Phase I/II Mexico Clinical Trial
We'll reach out to this number within 24 hrs